Electrochemical biosensors have emerged as indispensable detection tools with rapid advancements in recent years, offering high sensitivity, specificity, and cost-effectiveness for quantifying diverse analytes, including amino acids, proteins, pathogens, cells, antigens, and organic/inorganic compounds, thereby advancing analytical detection technologies across multiple fields. Aptamers, synthetic in vitro-evolved ligands with exceptional binding affinity and stability, serve as superior biorecognition elements for electrochemical sensing interfaces. Compared with other bioreceptors such as antibodies, they are generally easier and faster to produce, more uniform between batches, and easier to modify chemically; they also maintain greater stability than protein antibodies or enzymes across varying pH, temperature, and ionic conditions, enabling targeted recognition and measurable signal transduction. This review systematically summarizes recent advances in electrochemical aptasensors across three core domains: biomedical diagnostics (covering tumor markers, infectious disease pathogens, cardiovascular and metabolic biomarkers), food safety monitoring (targeting antibiotics, mycotoxins, foodborne pathogens, and pesticide residues), and environmental hazard detection (including heavy metals, toxic compounds, and biotoxins). Key technological innovations such as nanomaterial modification, signal amplification strategies, and novel sensor architectures are highlighted. Additionally, it critically discusses prominent challenges, including complex matrix interference, limited aptamer repertoires, poor reproducibility, and lack of standardization, along with future prospects. This work aims to provide a comprehensive reference for the rational design, optimization, and clinical/field application of next-generation electrochemical aptasensing technologies.
Shang et al. (Sun,) studied this question.